WO2006118488A2 - Processed sunflower black seed oil and use thereof in pharamac eut i cal and cosmetic compositions - Google Patents

Processed sunflower black seed oil and use thereof in pharamac eut i cal and cosmetic compositions Download PDF

Info

Publication number
WO2006118488A2
WO2006118488A2 PCT/SD2006/000001 SD2006000001W WO2006118488A2 WO 2006118488 A2 WO2006118488 A2 WO 2006118488A2 SD 2006000001 W SD2006000001 W SD 2006000001W WO 2006118488 A2 WO2006118488 A2 WO 2006118488A2
Authority
WO
WIPO (PCT)
Prior art keywords
protect
pharamac
eut
cal
oil
Prior art date
Application number
PCT/SD2006/000001
Other languages
French (fr)
Other versions
WO2006118488A3 (en
Inventor
Awad Ahmed Aboras
Original Assignee
Awad Ahmed Aboras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Awad Ahmed Aboras filed Critical Awad Ahmed Aboras
Publication of WO2006118488A2 publication Critical patent/WO2006118488A2/en
Publication of WO2006118488A3 publication Critical patent/WO2006118488A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Definitions

  • HIV Human Immunodeficiency Virus
  • HBV Hepatitis specially

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • AIDS & HIV (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)

Abstract

The medical and cosmetic oil of the sunflower, that produced of peeled seeds with no chemicals added nor heat processing. Used either as oral dosage or by rubbing the skin to improve the immunity system thus, treats all diseases.

Description

Sir/ Patent Registrar of Inventions
Subject: A Registration Application of Patent Invention (Sunflower
Oils Treat Diseases
I produce Sunflower oil by using modern and advanced methods, the invented oil is different and distinctive from any other sunflower oil has ever produced. It can be used with cosmetics and medical applications.
Now we use it as syrup and paint the body for the following diseases:
Human Immunodeficiency Virus (HIV)
Anemia
Diabetes
Heart disease
Vascular disease
Hepatitis specially (HBV)
Kidney disease
Urinary tract infection
Gastro enteritis & Dowel Inflammatory
Skin and soft tissue infections.
Best regards,
Inventor
Aboras Awad Ahmed

Claims

The Protection of Claims
To protect, have right to co-operate in a treaty agreement with other concerning the following
- To protect producing the oil from processed sunflower. - To protect adding my oil to other material to get medicines or cosmetics. - To protect processing sunflower black seed to produce oil. - To protect using this oil to treat human immunodeficiency virus (HlV)1 malignancies, diabetics and other diseases.
Inventor
Aburas Awad Ahmed
PCT/SD2006/000001 2005-02-24 2006-01-15 Processed sunflower black seed oil and use thereof in pharamac eut i cal and cosmetic compositions WO2006118488A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SD119805 2005-02-24
SD1198 2005-02-24

Publications (2)

Publication Number Publication Date
WO2006118488A2 true WO2006118488A2 (en) 2006-11-09
WO2006118488A3 WO2006118488A3 (en) 2008-10-23

Family

ID=37308409

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SD2006/000001 WO2006118488A2 (en) 2005-02-24 2006-01-15 Processed sunflower black seed oil and use thereof in pharamac eut i cal and cosmetic compositions

Country Status (1)

Country Link
WO (1) WO2006118488A2 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62198610A (en) * 1986-02-25 1987-09-02 Shiseido Co Ltd Cosmetic
CA2111417A1 (en) * 1993-12-14 1995-06-15 Jadwiga Kalinowska-Kowalik Composition for treating skin diseases
EP0662318A1 (en) * 1994-01-10 1995-07-12 L'oreal Cosmetic and/or dermatological composition containing salicylic acid derivatives and the solubilisation process of these derivatives
WO1995020313A1 (en) * 1994-01-31 1995-08-03 Consejo Superior De Investigaciones Cientificas Sunflower seeds and oil having a high stearic acid content
DE19615293A1 (en) * 1996-04-18 1997-10-23 Johann Dibart Propolis skin disorder salve
DE202005000870U1 (en) * 2005-01-20 2005-05-04 Reitenbach, Paul Deep peeling product for renewing and rejuvenating human facial skin comprises trichloroacetic acid, water, sunflower oil, Tween and glycerol
ES2277562A1 (en) * 2005-12-29 2007-07-01 F. Javier Porras Vila Sugar based skin cream e.g. for hands comprises a blend with sunflower oil talc powder honey royal jelly and preservatives
WO2008024036A1 (en) * 2006-08-24 2008-02-28 Awad Ahmed Aboras Sunflower - seed peeler

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2159628C2 (en) * 1996-07-01 2000-11-27 Малеева Галина Лаврентьевна Antiburn agent and method of preparation thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62198610A (en) * 1986-02-25 1987-09-02 Shiseido Co Ltd Cosmetic
CA2111417A1 (en) * 1993-12-14 1995-06-15 Jadwiga Kalinowska-Kowalik Composition for treating skin diseases
EP0662318A1 (en) * 1994-01-10 1995-07-12 L'oreal Cosmetic and/or dermatological composition containing salicylic acid derivatives and the solubilisation process of these derivatives
WO1995020313A1 (en) * 1994-01-31 1995-08-03 Consejo Superior De Investigaciones Cientificas Sunflower seeds and oil having a high stearic acid content
DE19615293A1 (en) * 1996-04-18 1997-10-23 Johann Dibart Propolis skin disorder salve
DE202005000870U1 (en) * 2005-01-20 2005-05-04 Reitenbach, Paul Deep peeling product for renewing and rejuvenating human facial skin comprises trichloroacetic acid, water, sunflower oil, Tween and glycerol
ES2277562A1 (en) * 2005-12-29 2007-07-01 F. Javier Porras Vila Sugar based skin cream e.g. for hands comprises a blend with sunflower oil talc powder honey royal jelly and preservatives
WO2008024036A1 (en) * 2006-08-24 2008-02-28 Awad Ahmed Aboras Sunflower - seed peeler

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBASE [Online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 1977, JUKES T H: "Sursum corda" XP002490331 Database accession no. EMB-1978231337 *
DATABASE EMBASE [Online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; December 2003 (2003-12), SORIGUER F ET AL: "Hypertension is related to the degradation of dietary frying oils" XP002490332 Database accession no. EMB-2004538992 & AMERICAN JOURNAL OF CLINICAL NUTRITION 200312 US, vol. 78, no. 6, December 2003 (2003-12), pages 1092-1097, ISSN: 0002-9165 *
DATABASE WPI Week 200116 2001, Thomson Scientific, London, GB; AN 2001-157312 XP002490333 MALEEVA GL: "Antiburn agent and method of preparation thereof" -& RU 2 159 628 C2 (MALEEVA GL) 27 November 2000 (2000-11-27) *
TUREGUN MURAT ET AL: "Sunflower oil in the treatment of hot tar burns" BURNS, vol. 23, no. 5, August 1997 (1997-08), pages 442-445, XP002490556 ISSN: 0305-4179 *

Also Published As

Publication number Publication date
WO2006118488A3 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
RU2325389C2 (en) Composition and derivatives of substituted azaindoloxoacetapiperazine characterized by antiviral activity
WO2007062107A3 (en) Immunostimulatory oligoribonucleotides
WO2005123651A8 (en) L-2-(α-HYDROXYPENTYL)BENZOATES, THE PREPARATION AND THE USE THEREOF
ATE418540T1 (en) GALLOYL PEPTIDES
BRPI0407140A (en) Therapeutic drug for viruses
ATE454139T1 (en) MEDICINAL PRODUCTS WITH SHIKONIN AS THE ACTIVE INGREDIENT
WO2006118488A2 (en) Processed sunflower black seed oil and use thereof in pharamac eut i cal and cosmetic compositions
CN105434467A (en) Chilblain therapeutic agent and production method thereof
PT1156830E (en) USING AN OLEO EMULSION IN WATER FOR THE PREPARATION OF A MEDICATION
JP2006342073A (en) Immunoactivity-enhancing ingredient, and food/drink and quasi-drug each containing the same
CN102512650A (en) Externally-used medicine for treating facial paralysis
JP2003265139A (en) Method for producing bio-protective immunogenic food for cancer cell and aids virus
RU2005130403A (en) MEANS FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH DECREASED BONE TISSUE METABOLISM
JP2002325828A5 (en)
JPH08119874A (en) Production of suppressor of aids virus and cancer cell
CN105232528A (en) Pharmaceutical composition and application thereof
BR102022009993A2 (en) MULTIPURPOSE COMPOUND FOR CURE OF COVID-19 AND DISEASES CAUSED BY ANY MICROORGANISMS AND PREVENTION OF CANCERS CAUSED BY FREE RADICALS (TANYCIN)
RU2452729C2 (en) Biphenyl derivatives and application thereof in treating hepatitis c
WO2006072239A3 (en) Use of cobalamines for treating intestinal diseases
CN106806744A (en) A kind of spray for treating tinea pedis
CN106074659A (en) A kind of acupoint plaster and using method thereof
WO2009082363A8 (en) Method and preparations for treating infection-allergic diseases
JP2006306810A (en) Anti-inflammatory agent
EP1611895A8 (en) Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals
Sinha et al. Role of nanoparticles for infectious control of viruses

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06716864

Country of ref document: EP

Kind code of ref document: A2